PLETHICO PHARMACEUTICALS LTD Q1 RESULTS
Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profit
Akum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June quarter, reversing a Rs 187.4 crore loss from FY24. Revenue also rose 5% YoY to Rs 1,091 crore.
India Inc: Key takeaways from Q1 results season
In Q1FY25, Bank and Auto stocks outperformed, while Infrastructure, Pharmaceuticals, and Metals lagged, resulting in modest 3% earnings growth. Revenue growth stayed at 9%. Real estate, pharmaceutical, and IT sectors highlighted notable revenue and profitability growth. Banks' NIMs remained stable, and auto sales surged, especially in two-wheelers and commercial vehicles.
Oil and gas spoil India Inc show in June Quarter
In the June 2024 quarter, India's industry saw modest growth with a 9.4% net profit increase, mainly due to lower refining and marketing margins in the oil and gas sector. Banking and finance sectors performed well with significant revenue growth. The overall operating margin declined to 17.4%. Future growth hinges on rural demand revival post-monsoon.
Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%
Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue from operations increased by 16.6% to Rs 1,815 crore. The company reported growth across Europe and Canada, emphasizing its successful integration of Sanofi's cardiovascular brands.
Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 27.8%.
Q1 results this week: HAL, Ola Electric, Vodafone Idea, IRFC, and Nykaa among 85 companies to announce quarterly earnings
Several widely followed companies, including Vodafone Idea, Hindustan Aeronautics (HAL), Mazagon Dock, Hero MotoCorp, IRFC, IRCTC, HUDCO, Apollo Hospitals, Samvardhana Motherson, GMR Airports Infrastructure, Nykaa, and Ola Electric will be releasing their June quarter report cards this week. Here’s the list:
- Go To Page 1
Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 crore
The company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 crore in Q1FY25.
JB Pharma Q1 Results: Net profit jumps 25% YoY to Rs 177 crore
The drug maker had reported a net profit of Rs 142 crore in the year-ago period.Revenue for the quarter rose 12% YoY to Rs 1004 crore
Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 crore
Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540 basis points on y-o-y basis to 15.3%
JB Pharma Q1 Results: Net profit rises 25% YoY to Rs 177 cr
"Our overall performance in the first quarter has been robust. We have reached a new milestone of Rs 1,000 crore in quarterly sales for the first time during any quarter, with improvement across all parameters - revenue, gross profit, operating profit and operating profit margin," CEO and Wholetime Director Nikhil Chopra stated.
Mankind Pharma Q1 Results: Net profit jumps 10% to Rs 543 crore
The drug maker reported net profit of Rs 494 crore in the corresponding period of previous year.Revenue from operations rose 12.2% YoY to Rs 2,893 crore in Q1FY25. On a quarter-on-quarter (QoQ) basis revenue and net profit increased 18.5% and 14%, respectively.
Q1 results today: Adani Total Gas, Adani Wilmar among 95 companies to announce earnings on Monday
Q1 Results Today 29 July 2024: Apollo Pipes, ASK Automotive, Bharat Electronics, Colgate Palmolive, CSB Bank, Elnet Technologies, Fredun Pharmaceuticals, Ideaforge Technologies, Indian Bank, NDTV, Pfizer India, Whirlpool, Wonderla Holidays among others will announce their quarterly results. | Latest Updates
Q1 results this week: ITC, SBI, TaMo, Zomato among 130 firms to announce earnings
This week, several prominent companies released their June quarter financial results. Firms like ITC, SBI, Adani Ports, Tata Motors, and M&M showcased their reports between July 29th and August 3rd. The updates offered a glimpse into their quarterly performance, engaging the attention of investors and stakeholders.
J&J Q2 Results: Pharma major beats Wall Street estimates on strong drug sales
Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara.
Q1 results, FII action among 10 factors to impact D-Street mood this week
Nifty gained 1.2%, driven by IT, energy, and pharma stocks. U.S. labor data, TCS earnings, Rupee vs. Dollar, Bank Nifty, oil prices, FIIs, IPO action, and dividends will influence markets next week. Bulls maintain strength with positive sentiment and broader market participation, expecting some consolidation.
Torrent Pharma, Glenmark Pharma shares jump up to 9% after Q4 results
Shares of Torrent Pharma and Glenmark Pharma surged post Q4 results. Torrent Pharma's net profit jumped 56% YoY while Glenmark Pharma reported increased losses. Motilal Oswal provides target prices for both companies.
Torrent Pharma Q4 Results: Net profit jumps 56% YoY to Rs 449 crore
Torrent Pharmaceuticals Ltd on Friday reported a 56.45 per cent jump in consolidated net profit to Rs 449 crore in the March quarter, riding on higher revenue.
Torrent Pharma board approves to raise Rs 5,000 crore
Torrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical company JB Pharma, according to a report by ET on Friday.
Sun Pharma shares tumble 5% but brokerages raise target up to Rs 1,785. Should you buy, sell or hold?
In Thursday's trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day's low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Zydus Lifesciences Q4 Results: Drug makers posts threefold YoY jump in net profit to Rs 1,182 crore
Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.
Alembic Pharma Q4 Results: Posts higher profit on strong N.America sales
Alembic Pharma Q4 Results: Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by strong sales, especially in the key North American market.
Lupin share price drops 5% post Q4 earnings
Lupin Share Price: Its revenue from operations in the same period jumped 12% YoY to Rs 4,961 crore as against Rs 4430 crore in the corresponding period of last year.
Lupin Q4 Results: Profit jumps 52% YoY to Rs 368 crore; revenue up 12%
Lupin reported a 52% YoY growth in net profit to Rs 368 crore for March 2024 quarter. Revenue increased by 12% to Rs 4,961 crore. The company declared a dividend of Rs 8 per share.
Q4 preview: 6 companies likely to report doubling of sales. Do you own any?
6 companies expected to double sales in Q4 with sectors like automobiles, banks, gas utilities, pharmaceuticals showing YoY sales growth. Sunteck Realty set for a significant jump in net sales.
Sun Pharma's steady Q3 earnings prompt target upgrades by brokerages. Should you buy?
The stock was trading with minor gains at the opening time and hit the day's high of Rs 1,430.45 on the NSE, up 0.84% over the Wednesday closing price.
Sun Pharma Q3 Results: Cons PAT rises 17% YoY to Rs 2,561 crore; Rs 8.5/sh dividend announced
Sun Pharmaceutical Industries reported a 17.4% YoY growth in net profit for Q4, beating estimates. Consolidated revenue grew 10% YoY. The company recommended an interim dividend payout. EBITDA rose 16% YoY and margins expanded. Raw material cost fell, but staff cost increased. India formulation sales and US formulation sales grew, while emerging markets formulation sales declined.
Dr Reddy's Q3 Results: Net profit jumps 11% YoY to Rs 1,379 crore
The company said the net profit was led by new products and base business market share gain in the US, and also new launches and strong volumes in Europe
Turnaround stocks: These 4 multibagger companies returned to profits in Q1; worth a look?
Among index majors, Axis Bank, UPL, Oil and Natural Gas Corporation, and Sun Pharmaceutical Industries witnessed a rebound in earnings in the June quarter.
Load More